Literature DB >> 20435434

Melatonin in septic shock: some recent concepts.

Venkataramanujan Srinivasan1, Seithikurippu R Pandi-Perumal, D Warren Spence, Hisanori Kato, Daniel P Cardinali.   

Abstract

Melatonin is a versatile molecule, synthesized not only in the pineal gland, but also in many other organs. Melatonin plays an important physiologic role in sleep and circadian rhythm regulation, immunoregulation, antioxidant and mitochondrial-protective functions, reproductive control, and regulation of mood. Melatonin has also been reported as effective in combating various bacterial and viral infections. Melatonin is an effective anti-inflammatory agent in various animal models of inflammation and sepsis, and its anti-inflammatory action has been attributed to inhibition of nitric oxide synthase with consequent reduction of peroxynitrite formation, to the stimulation of various antioxidant enzymes thus contributing to enhance the antioxidant defense, and to protective effects on mitochondrial function and in preventing apoptosis. In a number of animal models of septic shock, as well as in patients with septic disease, melatonin reportedly exerts beneficial effects to arrest cellular damage and multiorgan failure. The significance of these actions in septic shock and its potential usefulness in the treatment of multiorgan failure are discussed.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20435434     DOI: 10.1016/j.jcrc.2010.03.006

Source DB:  PubMed          Journal:  J Crit Care        ISSN: 0883-9441            Impact factor:   3.425


  30 in total

1.  Melatonin in aging and disease -multiple consequences of reduced secretion, options and limits of treatment.

Authors:  Rüdiger Hardeland
Journal:  Aging Dis       Date:  2011-02-10       Impact factor: 6.745

Review 2.  Utilizing melatonin to combat bacterial infections and septic injury.

Authors:  Wei Hu; Chao Deng; Zhiqiang Ma; Dongjin Wang; Chongxi Fan; Tian Li; Shouyin Di; Bing Gong; Russel J Reiter; Yang Yang
Journal:  Br J Pharmacol       Date:  2017-03-21       Impact factor: 8.739

3.  Administration of Exogenous Melatonin After the Onset of Systemic Inflammation Is Hardly Beneficial.

Authors:  Lisa Brencher; Maren Oude Lansink; Katharina Effenberger-Neidnicht
Journal:  Inflammation       Date:  2017-10       Impact factor: 4.092

4.  Melatonin ameliorates brain injury induced by systemic lipopolysaccharide in neonatal rats.

Authors:  C-S Wong; G-M Jow; A Kaizaki; L-W Fan; L-T Tien
Journal:  Neuroscience       Date:  2014-03-05       Impact factor: 3.590

5.  Beneficial Effects of Exogenous Melatonin in Acute Staphylococcus aureus and Escherichia coli Infection-Induced Inflammation and Associated Behavioral Response in Mice After Exposure to Short Photoperiod.

Authors:  Biswadev Bishayi; Rana Adhikary; Ajeya Nandi; Sahin Sultana
Journal:  Inflammation       Date:  2016-12       Impact factor: 4.092

Review 6.  Melatonin for the treatment of sepsis: the scientific rationale.

Authors:  Ruben Manuel Luciano Colunga Biancatelli; Max Berrill; Yassen H Mohammed; Paul E Marik
Journal:  J Thorac Dis       Date:  2020-02       Impact factor: 2.895

7.  Short- and Long-Term Protective Effects of Melatonin in a Mouse Model of Sepsis-Associated Encephalopathy.

Authors:  Mu-Huo Ji; De-Guo Xia; Lan-Yue Zhu; Xia Zhu; Xiao-Yan Zhou; Jiang-Yan Xia; Jian-Jun Yang
Journal:  Inflammation       Date:  2018-03       Impact factor: 4.092

8.  Pharmacokinetics of Melatonin: The Missing Link in Clinical Efficacy?

Authors:  Lars Peter Holst Andersen; Ismail Gögenur; Jacob Rosenberg; Russel J Reiter
Journal:  Clin Pharmacokinet       Date:  2016-09       Impact factor: 6.447

9.  Temporal disorganization of circadian rhythmicity and sleep-wake regulation in mechanically ventilated patients receiving continuous intravenous sedation.

Authors:  Brian K Gehlbach; Florian Chapotot; Rachel Leproult; Harry Whitmore; Jason Poston; Mark Pohlman; Annette Miller; Anne S Pohlman; Arlet Nedeltcheva; John H Jacobsen; Jesse B Hall; Eve Van Cauter
Journal:  Sleep       Date:  2012-08-01       Impact factor: 5.849

Review 10.  Neuroprotective effect of melatonin: a novel therapy against perinatal hypoxia-ischemia.

Authors:  Daniel Alonso-Alconada; Antonia Alvarez; Olatz Arteaga; Agustín Martínez-Ibargüen; Enrique Hilario
Journal:  Int J Mol Sci       Date:  2013-04-29       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.